Browse > Article

Trial for Drug Susceptibility Testing of Mycobacterium tuberculosis with Live and Dead Cell Differentiation  

Ryu, Sung-Weon (Department of Microbiology, Korean Institute of tuberculosis)
Kim, Hyun-Ho (Graduate School of Biotechnology, Korea University)
Bang, Mun-Nam (Department of Microbiology, Korean Institute of tuberculosis)
Park, Young-Kil (Department of Microbiology, Korean Institute of tuberculosis)
Park, Sue-Nie (Korea Food & Drug Administration)
Shim, Young-Soo (Seoul National University College of Medicine)
Kang, Seongman (Graduate School of Biotechnology, Korea University)
Bai, Gill-Han (Department of Microbiology, Korean Institute of tuberculosis)
Publication Information
Tuberculosis and Respiratory Diseases / v.56, no.3, 2004 , pp. 261-268 More about this Journal
Abstract
Background : The resurgence of tuberculosis and outbreaks of multidrug resistant (MDR) tuberculosis have increased the emphasis for the development of new susceptibility testing of the Mycobacterium tuberculosis for the effective treatment and control of the disease. Conventional drug susceptibility testings, such as those using egg-based or agar-based media have some limits, such as the time required and difficulties in determining critical inhibitory concentrations, but these are still being used in many diagnostic laboratories because of no better lternatives, considering cost and accuracy. To overcome these limits, a rapid and simple method for new susceptibility testing, using live and dead assays, was applied for a bacterial cell viability assay to distinguish dead from live bacterial cells based on two-color fluorescence. Materials and Methods Strains : Forty strains were used in this study, 20 susceptible to all antituberculosis drugs and the other 20 resistant to the four first line antituberculosis drugs isoniazid, rifampicin, streptomycin and ethambutol. Antibiotics : The four antibiotics were dissolved in 7H9 broth to make the following solutions: $0.1{\mu}g\;isoniazid(INH)/m{\ell}$, $0.4{\mu}g\;rifampicin(RMP)/m{\ell}$, $4.0{\mu}g\;streptomycin(SM)/m{\ell}$ and $4.0{\mu}g\;ethambutol(EMB)/m{\ell}$. Results : Live and dead Mycobacterium tuberculosis cells fluoresced green and red with the acridin (Syto 9) and propidium treatments, respectively. These results are very well accorded with conventional drug susceptibility testing by proportional method on Lowensen-Jensen media (L-J) containing 4 drugs (INH, RMP, EMB and SM), showing a 93.7 % accordance rate in susceptible strains and 95% in resistant strains. Conclusion : The results of the drug susceptibility testing using the live and dead bacterial cell assay showed high accordance rates compared with the conventional proportion method on L-J. This finding suggests that the live and dead bacterial cell assay can be used as an alternative to conventional drug susceptibility testing for M. tuberculosis strains.
Keywords
Tuberculosis; Live and dead cell; Susceptibility testing;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Telzak EE, Sepkowitz K, Alpert P, Man nheimer S, Merdard F, el-Sadr W, et al.Muotidrug-resistant tuberculosis in pateints without HIV infection. N Eng J Med 1995:333(14):907-11
2 Kim SJ. Current problems of drug-resistant tuberculosis and its control. Kekkaku. 2002;Nov;77(11):735-40
3 G.A. McFeters, A. Singh, S. Byun, P.R. Callis and S. Williams. Acridine orangestaining reaction as an index of physiological activity in Escherichia coli. J Microbiol Methods. 1991;13:87-97
4 Zapata P, Arbeloa M, Aznar J. Evaluation of Mycobacteria Growth Indicator Tube (MGIT) for drug susceptibility testing of Mycobac terium tuberculosis isolates from clinical specimens. Clin Microbiol Infect 1999; 5:227-230
5 Decker EM. The ability of direct fluore scence-based, two-colour assays to detect different physiological states of oral strepto cocci. Lett Appl Microbiol 2001:33:188-192
6 Armstrong DW, He L. Determination of cell viability in single or mixed samples using capillary electrophoresis laser-induced fluore scence microfluidic systems. Anal Chem 2001:73:4551-4557
7 Villanova, PA. Antimycobacterial suscepti bility testing for Mycobacterium tuberculosis. Tentative standard M24-T. National Commit tee for Clinical Laboratory Standards. 1995; NCCLS-National Committee for Clinical Laboratory Standards
8 McClatchy JK. Susceptibility testing of mycobacteria. Lab Med 1978;9:47-52
9 Fernandez M, Sanchez. Nuclease activities and cell death processes associated with the development of surface cultures of Strepto myces antibioticus ETH 7451. J. Microbiology 2002:148:405-412
10 Espinal MA, Laszlo a, Simonsen L, Boul ahbal F, Kim SJ, Reniero A, Hoffner S, et al., Global trends in resistance to antituber culosis drugs. N Eng J Med 2001;344:1294-303
11 Thornton CG, MacLellan KM, Brink TL, Passen S. Characterization of the suscepti bility of mycobacteria in BACTEC 12B media containing PANTA that had been supplemented with ceftazidime, and charac terization of the individual components of PANTA in the presence of C(18)-carboxy propylbetaine. J Microbiol Methods. 2004:Feb;56(2):243-51
12 Howard DH, Scott RD 2nd, Packard R, Jones D. The global impact of drug resistance. Clin Infect Dis. 2003;15;36(Suppl 1):S4-10
13 Espinal MA. The global situation of MDRTB. Tuberculosis (Edinb). 2003;83(1-3):44-51
14 Kontos F, Maniati M, Costopoulos C, Gitti Z, Nicolaou S, Petinaki E, Anagnostou S, Tselentis I, Maniatis AN. Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study. J Microbiol Methods. 2004:Feb;56(2):291-4